EUVIMEDEUVIMED entdecken
Crossref

Advances in Targeted Pyrazinamide Delivery via Functionalized Chitosan Nanoparticles

Anishka Sinha, Amit Kumar Sharma, Aafreen Aafreen, Ankit Chaurasia

International Journal of Drug Delivery Technology · 17.06.2026 · 16 (55s)

DOI: 10.25258/ijddt.16.55s.34 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 17.06.2026. Verfasst von Anishka Sinha und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycobacterium tuberculosis causes tuberculosis (TB), which continues to be a serious health risk in the world; there are around 10 million cases of TB each year and about 1.2 million deaths. Pyrazinamide (PZA) is a first line anti tubercular drug which is highly bactericidal against the intracellular mycobacteria especially in acidic environment. Its clinical efficacy is, however, hampered by low bioavailability, insufficient intracellular uptake, systemic toxicity and the increasing problem of drug resistance. Chitosan nanoparticles are becoming a promising drug delivery system because of the following properties; biocompatible, biodegradable, cationic and mucoadhesive properties. The review aims to provide a comprehensive overview of the progress in targeted PZA delivery systems based on functionalized chitosan nanoparticles, condensing the existing information from 2014 to 2024. Chemistry of chitosan, methods of synthesis of nanoparticles, targeting the ligands, cellular uptake mechanism and translation of the nanoparticles from preclinical to clinical settings are discussed. Moreover, the synergic effect of combination therapies, the challenges in the intracellular delivery, and future prospects for overcoming drug resistance and enhancing therapeutic efficacy are discussed. This review aims to give insights to the development of good nanoparticulate formulations for improving the anti-tuberculous treatment.

Zitieren

APA

Sinha, A., Sharma, A. K., Aafreen, A., & Chaurasia, A. (2026). Advances in Targeted Pyrazinamide Delivery via Functionalized Chitosan Nanoparticles. International Journal of Drug Delivery Technology, 16(55s). https://doi.org/10.25258/ijddt.16.55s.34

Vancouver

Sinha A, Sharma AK, Aafreen A, Chaurasia A. Advances in Targeted Pyrazinamide Delivery via Functionalized Chitosan Nanoparticles. International Journal of Drug Delivery Technology. 2026;16(55s). doi:10.25258/ijddt.16.55s.34

BibTeX
@article{Sinha2026,
  author = {Sinha, Anishka and Sharma, Amit Kumar and Aafreen, Aafreen and Chaurasia, Ankit},
  title = {Advances in Targeted Pyrazinamide Delivery via Functionalized Chitosan Nanoparticles},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {55s},
  doi = {10.25258/ijddt.16.55s.34}
}
Kostenlos starten →